Guangzhou Pharmaceutical Group Co., Ltd. is a wholly state-owned company authorized by Guangzhou Municipal Government to operate state-owned assets. Mainly engaged in R&D and Chinese patent medicine manufacturing, botanical drugs, chemical raw materials, preparations, biological drugs, large-scale health care products, trade logistics distribution, medical and health services. It is a large enterprise group integrating science, industry and trade. In 20 17 years, GPHL realized industrial and commercial sales income of 102 1 100 million yuan. In 20 18, the industrial and commercial sales revenue was11600 million yuan, a year-on-year increase of 13 yuan, and the total profit was 41660 million yuan, a year-on-year increase of 2 billion yuan.
GPHL has nearly 30 listed companies and member companies Guangzhou Baiyun Mountain Pharmaceutical Group Co., Ltd. (listed in Hong Kong H shares and Shanghai A shares). After years of careful construction and accelerated development, it has gradually formed three new formats: Great South Medicine, Great Health, Great Commerce, Great Medical Care, E-commerce, Capital Finance and Medical Devices. In 20 17, GPHL became the second state-owned enterprise in Guangzhou with an aircraft carrier exceeding10 billion yuan, ranking 165 among the top 500 Chinese enterprises in 20 18, with sales revenue of 201kloc-0/6 billion yuan. Ranked first in the list of top 100 pharmaceutical enterprises in China for many years. GPHL has a history of 4 19 years, and it is also recognized as the longevity gene of red gene.